Recombinant Mouse DARC Protein，His & GST

DARC (Duffy Antigen Receptor for Chemokines), a membrane protein expressed on red blood cells and various other cell types, has garnered significant attention in biomedical research due to its multifaceted role in immune response and disease processes. Initially identified as the receptor for the Duffy blood group antigens, DARC plays a crucial role in the binding and transport of chemokines, which are pivotal signaling molecules involved in inflammation and immune cell trafficking. Studies have revealed its involvement in various diseases, including malaria, where the absence of DARC in certain populations provides resistance to Plasmodium vivax infection. This unique characteristic has spurred investigations into the potential therapeutic applications of DARC, particularly in modulating immune responses for various conditions, including autoimmune disorders and cancer. Moreover, the structural and functional analysis of DARC as a recombinant protein facilitates the understanding of its interactions with chemokines and other cellular receptors, paving the way for novel drug designs and therapeutic interventions. Research into DARC is further complicated by existing genetic variations among different human populations, adding a layer of complexity to its role in health and disease. Consequently, the study of DARC recombinant proteins not only aids in elucidating its biological functions but also contributes to the broader understanding of human immunology and disease resistance mechanisms.